Moelis & Company - MC Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $50.80
  • Forecasted Upside: -0.33%
  • Number of Analysts: 6
  • Breakdown:
  • 2 Sell Ratings
  • 4 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$50.97
▼ -0.29 (-0.57%)

This chart shows the closing price for MC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Moelis & Company Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MC

Analyst Price Target is $50.80
▼ -0.33% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Moelis & Company in the last 3 months. The average price target is $50.80, with a high forecast of $58.00 and a low forecast of $38.00. The average price target represents a -0.33% upside from the last price of $50.97.

This chart shows the closing price for MC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 6 polled investment analysts is to reduce stock in Moelis & Company. This Reduce consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
10/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
1/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
4/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
7/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
10/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
1/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
3/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/9/2024JMP SecuritiesReiterated RatingMarket PerformLow
3/26/2024UBS GroupLower TargetSell ➝ Sell$46.00 ➝ $45.00Low
3/13/2024The Goldman Sachs GroupUpgradeSell ➝ Neutral$53.00 ➝ $58.00Low
2/8/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$46.00 ➝ $57.00Low
1/29/2024Keefe, Bruyette & WoodsReiterated RatingMarket Perform$56.00Low
12/19/2023The Goldman Sachs GroupBoost TargetSell ➝ Sell$41.00 ➝ $47.00Low
11/3/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$39.00 ➝ $38.00Low
10/3/2023UBS GroupBoost TargetSell ➝ Sell$29.00 ➝ $30.00Low
4/12/2023Morgan StanleyLower TargetUnderweight$30.00 ➝ $29.00Low
2/9/2023The Goldman Sachs GroupBoost TargetSell$38.00 ➝ $42.00Low
1/11/2023The Goldman Sachs GroupDowngradeNeutral ➝ Sell$40.00 ➝ $37.00Low
1/9/2023UBS GroupLower TargetSell$32.00 ➝ $30.00Low
11/3/2022JPMorgan Chase & Co.Lower TargetNeutral$42.00 ➝ $40.00Low
11/3/2022Keefe, Bruyette & WoodsDowngradeMarket Perform ➝ Underperform$40.00 ➝ $37.00Low
10/7/2022The Goldman Sachs GroupLower TargetNeutral$43.00 ➝ $38.00Low
9/23/2022UBS GroupDowngradeNeutral ➝ Sell$43.00 ➝ $35.00Low
7/28/2022UBS GroupBoost TargetNeutral$40.00 ➝ $43.00Low
7/18/2022Morgan StanleyDowngradeEqual Weight ➝ Underweight$53.00 ➝ $36.00Low
7/11/2022Wolfe ResearchDowngradePeer Perform ➝ Underperform$42.00N/A
7/8/2022Piper SandlerLower TargetNeutral$50.00 ➝ $45.00N/A
7/6/2022UBS GroupDowngradeBuy ➝ Neutral$54.00 ➝ $40.00N/A
4/28/2022Piper SandlerDowngradeOverweight ➝ Neutral$52.00 ➝ $50.00High
4/12/2022The Goldman Sachs GroupLower TargetNeutral$50.00 ➝ $45.00Medium
4/7/2022Piper SandlerLower TargetOverweight$61.00 ➝ $52.00High
4/6/2022Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$57.00High
3/9/2022Piper SandlerLower TargetOverweight ➝ Overweight$70.00 ➝ $61.00High
3/8/2022Morgan StanleyLower TargetEqual Weight$65.00 ➝ $53.00Low
2/11/2022Piper SandlerUpgradeNeutral ➝ Overweight$78.00 ➝ $70.00High
2/10/2022Morgan StanleyLower TargetEqual Weight$68.00 ➝ $65.00High
1/6/2022The Goldman Sachs GroupUpgradeSell ➝ Neutral$68.00 ➝ $65.00High
1/4/2022UBS GroupLower TargetBuy$85.00 ➝ $73.00Medium
12/17/2021Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$77.00High
12/8/2021Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$75.00 ➝ $68.00High
10/11/2021Morgan StanleyBoost TargetEqual Weight$63.00 ➝ $68.00Low
7/22/2021Morgan StanleyBoost TargetEqual Weight$60.00 ➝ $63.00High
6/17/2021Wolfe ResearchUpgradeUnderperform ➝ Peer Perform$63.00High
4/15/2021JMP SecuritiesReiterated RatingMarket Outperform ➝ Market PerformHigh
4/9/2021JMP SecuritiesDowngradeOutperform ➝ Market PerformMedium
4/7/2021Morgan StanleyBoost TargetEqual Weight$57.00 ➝ $60.00Low
3/16/2021Piper SandlerBoost Target$58.00 ➝ $68.00Low
2/11/2021Morgan StanleyBoost TargetEqual Weight$55.00 ➝ $57.00Low
1/11/2021Morgan StanleyBoost TargetEqual Weight$52.00 ➝ $55.00Medium
1/7/2021JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$34.00 ➝ $50.00N/A
1/5/2021UBS GroupUpgradeNeutral ➝ Buy$40.00 ➝ $56.00N/A
12/14/2020Morgan StanleyBoost TargetEqual Weight$41.00 ➝ $52.00Medium
10/27/2020Piper SandlerBoost TargetNeutral$37.00 ➝ $41.00Medium
10/12/2020Morgan StanleyBoost TargetEqual Weight$29.00 ➝ $41.00Low
10/9/2020JMP SecuritiesBoost TargetMarket Outperform$37.00 ➝ $42.00Low
10/9/2020Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$40.00Medium
10/2/2020UBS GroupUpgradeSell ➝ Neutral$38.00High
8/5/2020The Goldman Sachs GroupDowngradeNeutral ➝ Sell$27.00 ➝ $24.00Medium
7/30/2020Piper SandlerLower TargetNeutral$32.00 ➝ $31.00Medium
7/30/2020Morgan StanleyLower TargetEqual Weight$31.00 ➝ $29.00High
7/22/2020Wolfe ResearchInitiated CoverageUnderperform$19.00High
7/13/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$34.00 ➝ $27.00High
7/10/2020Piper SandlerDowngradeOverweight ➝ Neutral$40.00 ➝ $32.00High
7/7/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$20.00 ➝ $26.00High
4/14/2020UBS GroupDowngradeNeutral ➝ Sell$22.00Low
4/9/2020JMP SecuritiesLower TargetMarket Outperform$45.00 ➝ $39.00Low
4/9/2020Morgan StanleyLower TargetEqual Weight$37.00 ➝ $31.00Medium
3/25/2020UBS GroupLower TargetNeutral$33.00 ➝ $28.00Low
3/23/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$20.00Medium
2/6/2020JPMorgan Chase & Co.Boost TargetOverweight$44.00 ➝ $49.00High
2/6/2020Buckingham ResearchBoost TargetBuy$39.00 ➝ $41.00High
1/26/2020Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$34.00 ➝ $39.00Low
12/11/2019Morgan StanleyLower TargetEqual Weight$37.00 ➝ $35.00Medium
10/9/2019Buckingham ResearchLower TargetBuy$44.00 ➝ $39.00Low
10/8/2019Morgan StanleyLower TargetEqual Weight$41.00 ➝ $39.00Medium
7/31/2019Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Market Perform$42.00 ➝ $39.00Low
7/11/2019Buckingham ResearchLower TargetBuy$53.00 ➝ $44.00Medium
7/8/2019Morgan StanleyLower TargetEqual Weight$45.00 ➝ $41.00Low
(Data available from 4/19/2019 forward)

News Sentiment Rating

0.48 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 15 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/22/2023
  • 2 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
10/22/2023
  • 2 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
11/21/2023
  • 2 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
12/21/2023
  • 6 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
1/20/2024
  • 19 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
2/19/2024
  • 17 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/20/2024
  • 7 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
4/19/2024

Current Sentiment

  • 7 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
Moelis & Company logo
Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory. The company offers its services to public multinational corporations, middle market private companies, financial sponsors, entrepreneurs, governments, and sovereign wealth funds. It operates in North and South America, Europe, the Middle East, Asia, and Australia. The company was founded in 2007 and is headquartered in New York, New York.
Read More

Today's Range

Now: $50.97
Low: $50.83
High: $51.82

50 Day Range

MA: $54.49
Low: $51.08
High: $57.45

52 Week Range

Now: $50.97
Low: $33.87
High: $58.67

Volume

373,731 shs

Average Volume

626,491 shs

Market Capitalization

$3.63 billion

P/E Ratio

N/A

Dividend Yield

4.70%

Beta

1.35

Frequently Asked Questions

What sell-side analysts currently cover shares of Moelis & Company?

The following equities research analysts have issued reports on Moelis & Company in the last year: JMP Securities, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, and UBS Group AG.
View the latest analyst ratings for MC.

What is the current price target for Moelis & Company?

5 Wall Street analysts have set twelve-month price targets for Moelis & Company in the last year. Their average twelve-month price target is $50.80, suggesting a possible downside of 0.3%. The Goldman Sachs Group, Inc. has the highest price target set, predicting MC will reach $58.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $38.00 for Moelis & Company in the next year.
View the latest price targets for MC.

What is the current consensus analyst rating for Moelis & Company?

Moelis & Company currently has 2 sell ratings and 4 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for MC.

What other companies compete with Moelis & Company?

How do I contact Moelis & Company's investor relations team?

Moelis & Company's physical mailing address is 399 PARK AVENUE 5TH FLOOR, NEW YORK NY, 10022. The asset manager's listed phone number is (212) 883-3800 and its investor relations email address is [email protected]. The official website for Moelis & Company is www.moelis.com. Learn More about contacing Moelis & Company investor relations.